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Approach to Gastroesophageal 
Reflux: A Cause of Chest Pain in 
Infants with Congenital Heart 
Disease
Mehmet Semih Demirtaş
Abstract
The life expectancy and quality of life of infants with congenital heart disease 
have increased in the last 30 years with significant advances in technological 
facilities, treatment methods, and surgeries. GER is a condition that can be seen 
in infants with CHD, which needs to be well followed up and to be differentiated 
between physiological and nonphysiological reflux. GER is a physiological condi-
tion that is common in infants with CHD and usually resolves spontaneously in the 
first 6–12 months of life. If the baby has adequate weight gain and nutrition status 
and there is no abnormal restlessness, the baby is considered to be uncomplicated 
GER. GERD is a pathological clinical entity that is accompanied by insufficient 
weight gain, esophagitis, and persistent respiratory system findings. When gas-
troesophageal reflux disease is considered, the first thing to be done is to complete 
the detailed anamnesis and physical examination of the infant. The reflux status 
of the infants can be examined with the surveys that were prepared for GERD 
and followed up for 1–2 months. If necessary, diagnostic methods such as esopha-
geal pH monitoring and radiological and endoscopic examinations can be used. 
Conservative approaches such as thickening of formulas and thickening of formulas 
and positional feeding are the the first treatment approaches for reflux.
Keywords: congenital heart disease, gastroesophageal reflux disease, infant, 
treatment, surveys
1. Introduction
The prevalence of congenital heart disease (CHD) is known to be approximately 
0.5–0.8% in all live births [1]. It is estimated that approximately 30–35% of chil-
dren with CHD require medical treatment, interventional procedures, or surgical 
treatment [2]. Over the last 30 years, significant advances in surgical techniques 
and medical treatment have been made in the treatment of CHD in the world [3]. 
Nutritional status of CHD patients in the first year has an important role in growth 
and neurodevelopmental functions. GERD, which is closely related to nutrition and 
malnutrition, should be considered in these patients [4].
Gastroesophageal reflux is a common condition in children in all age groups, 
with gastric contents retrograde passage to the esophagus, even pharynx and 
mouth. This condition is defined as gastroesophageal reflux disease (GERD) if it 
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continues more frequently and continuously and causes worrisome symptoms and 
undesirable consequences [5]. Especially, it results in esophagitis or other esopha-
geal symptoms or symptoms of the respiratory system.
2. Definition
Gastroesophageal reflux is a physiological condition that may occur in healthy 
infants, children, and adults. It usually occurs in very short episodes (<3 minutes) 
and in the postprandial period without any symptom, esophageal damage, or 
complications. If these reflux processes cause worrisome symptoms and unwanted 
conditions, GERD is in question [6, 7].
Regurgitation refers to reflux in the oropharynx, while vomiting refers to the 
gastric contents coming out of the mouth. There is no need to be with repetition 
and any coercion. The use of these terms is intertwined in clinical practice, and 
no definite distinction is made. They are perceived as different states of the same 
process. Symptoms occur for many reasons (Table 1).
3. Epidemiology
A study of 948 infants in the United States reported a prevalence of reflux in 
the 4–6 months of life as 67% which has decreased to 5% by 10–12 months of age. 
Similarly in the study with 602 babies in India, it showed that the prevalence of gas-
troesophageal reflux, which was 55% in the first 6 months of life, decreased to 4% 
at 1 year of age [8, 9]. Epidemiological studies suggest that gastroesophageal reflux 
in infancy with CHD can be seen from the first month of life and the frequency 
of occurrence reaches to the peak around the fourth month, most of them recover 
after the age of 1 year, almost all of them at the age of 2 [10].
There is also a genetic predisposition to GERD. In addition to known GERD 
symptoms in some families, the incidence of endoscopic esophagitis, hiatus hernia, 
Barrett’s esophagus, and adenocarcinoma has been shown [11, 12]. Genetic factors 
Causes of vomiting
Gastrointestinal obstruction
Pyloric stenosis
Malrotation
Intestinal duplication
Hirschsprung’s disease
Antral/duodenal web
Foreign body
Neurological
Hydrocephalus
Subdural hematoma
Intracranial hemorrhage
Intracranial mass
Infant migraine
Chiari malformation
Renal
Obstructive uropathy
Renal insufficiency
Toxic
The lead
Iron
Vitamins A and D
Other gastrointestinal causes
Achalasia
Gastroparesis
Gastroenteritis
Peptic ulcer
Eosinophilic esophagitis 
gastroenteritis
Food allergy
Infectious
Sepsis
Meningitis
Urinary infection
Pneumonia
Otitis media
Cardiac
Congestive heart failure
Vascular ring
Metabolic/endocrine
Galactosemia
Hereditary fructose intolerance
Urea cycle defects
Amino and organic acidemias
Congenital adrenal hyperplasia
Table 1. 
Differential diagnosis in vomiting infants.
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which the 9q22-9q31 gene was mapped with infantile gastroesophageal reflux were 
thought to play a role in the concordance of gastroesophageal reflux in monozygotic 
twins compared to dizygotic twins [13].
Regurgitation is common in infants. However, typically around 1 year of age, it 
decreases or completely recovers. Regurgitation usually occurs in late infancy, but  
there is a weak relationship with GERD that occurs later in life. For example, 
frequent regurgitation in infancy and GERD in the mother (not the father) are 
risk factors that increase the occurrence of reflux-related symptoms in childhood 
[14]. In addition, it has been shown in a recent study that the psychopathological 
personality traits of the mother negatively affect the baby’s eating behavior and are 
effective in the development of reflux [15].
In a prospective study, it was found that babies with frequent vomiting more 
than 90 days in the first 2 years of life showed more adult symptoms of reflux at the 
age of 8–9 years [16].
4. Pathophysiology
The lower esophageal sphincter forms a functional barrier between the stomach 
and the esophagus and prevents the retrograde passage of stomach contents (acid, 
pepsin, sometimes bile) to the esophagus [17]. In addition, factors facilitating 
gastroesophageal reflux in CHD infants are the following:
1. Antireflux barrier dysfunction
2. Inadequate clearance mechanism of the esophagus
3. Impairment of esophageal mucosal resistance
4. Delay in gastric emptying
4.1 Antireflux barrier dysfunction
The physiological structure formed by the circular muscles, diaphragm cruses, and 
phrenoesophageal ligament in the esophagogastric junction forms the lower esopha-
geal sphincter (LES) which acts as the primary barrier function for reflux. In addition, 
the His angle between the esophagus and fundus and the intraabdominal segment of 
the esophagogastric junction are other components of the antireflux barrier.
The main problem leading to primary gastroesophageal reflux is not the loose 
of the lower esophageal sphincter; it is known that there are transient relaxations 
lasting longer than 5 seconds, independent of swallowing [17, 18]. Also some 
hormones (cholecystokinin, glucagon, vasoactive intestinal peptide (VIP), nitric 
oxide (NO), dopamine, secretin, and estrogen), drugs (atropine), and nutrients 
(peppermint, and cocoa) may contribute to GERD by reducing LES pressure [17]. 
In addition, the presence of stress associated with intensive treatment periods and 
interventions in complicated CHD patients may lead to increased catecholamine 
levels. Therefore, it may increase the expression of acid secretion and cause reflux 
formation [19].
4.2 Inadequate clearance mechanism of the esophagus
Physiological reflux attacks return the secretions and nutrients that escaped 
from the stomach to the esophagus for a very short period of time with the effect of 
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normal esophageal peristalsis and gravity. In this way, acid, pepsin, and bile which 
may cause inflammation when it comes into contact with the esophageal mucosa 
are removed. However, the acid which has not been cleared from the esophageal 
mucosa is neutralized by swallowing saliva at the alkaline pH. The aim is to remove 
the gastric contents that will cause inflammation in the esophageal mucosa. 
Disruption of these natural mechanisms increases the exposure to reflux [20].
4.3 Impairment of esophageal mucosal resistance
The mucus layer and bicarbonate concentration covering the esophageal epi-
thelium, the connections between epithelial cell membrane and cells, intra- and 
extracellular buffers, blood flow at the postepithelial level, and acid-base balance in 
the tissue are the factors that provide the resistance of the esophageal mucosa.
4.4 Delay in gastric emptying
Breast milk is known to have a healing effect on the intestinal mucosa and is 
well absorbed from the mucosa. However, it cannot provide sufficient energy 
support alone in infants with CHD. Therefore, high-energy density formulas used 
in patients receiving nutritional support due to increased energy support cause 
reflux by delaying gastric emptying. Increased fluid and sodium load, especially in 
patients with heart failure, increases the existing failure and therefore leads to mal-
nutrition and increased metabolic consumption. In the presence of hepatomegaly 
and ascites, gastric emptying is delayed due to the compression of the stomach, and 
this delay causes gastroesophageal reflux [3, 21, 22].
Impaired gastrointestinal motility, the presence of protein-losing enteropathy, 
and the presence of mucosal atrophy secondary to decreased splanchnic blood flow 
significantly slow the frequency of food elimination and gastric emptying in infants 
with CHD [1, 4]. Heart failure, especially in infants with critical congenital heart 
disease, causes some gastrointestinal problems in addition to the findings of the pres-
ent disease. It causes intestinal edema, malabsorption, steatorrhea, and protein-losing 
enteropathy, which cause malnutrition. If the clinical situation cannot be controlled 
and progresses, it forms the basis for gastroesophageal reflux disease [4, 10, 23].
Animasahun et al. reported in their study that cyanosis was the most common 
presentation of congenital heart disease in children [14]. In a survey based on the 
frequency of GERD in CHD infants, cyanosis was found to be more frequent in favor 
of reflux in the group with cyanotic CHD. However, it was stated that this finding is 
not specific for reflux in CHD infants because this may also be caused by disease [10].
As a result insufficiency of lower esophageal sphincter, transient LES loosen-
ing, deterioration of esophageal dysmotility and esophageal clearance, stress and 
hormonal factors that increase gastric acidity, as well as delayed emptying of the 
stomach and using high-energy density formulas play a role in reflux pathophysiol-
ogy of CHD patients.
5. Clinical presentations
A thorough history, a detailed physical examination, and warning symptoms to 
exclude differential diagnoses are sufficient to make a clinical diagnosis of uncom-
plicated infant reflux. Regurgitation is the most frequent symptoms of infantile 
gastroesophageal reflux. In contrast to gastroesophageal reflux that occurs after 
birth, regurgitation may not be pronounced until the second or third week of life. 
The typical symptom of physiological reflux is effortless and painless regurgitation 
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which is called “happy spitter” [24]. A detailed nutritional history including the 
frequent amount of vomiting and regurgitation, feeding type (breastfeeding or 
formula), turning blue/purple in feeding time, hiccups, and behavior of the baby 
during feeding should be obtained.
In order to protect the airway from reflux during infancy, the dystonic posture 
formed by throwing back the baby’s head and sometimes the body can be mistak-
enly perceived as “seizure.” This condition, known as “Sandifer syndrome,” protects 
the airways from reflux or reduces abdominal pain caused by acid reflux. This 
position regresses with antireflux therapy [25, 26].
Unexplained crying attacks and restless behaviors during the day are 
associated with various conditions in infants. Healthy infants have crying 
attacks and restlessness on an average between 0 and 2 hours during the day. 
Excessive crying attacks and increased restlessness expressed by the family 
should be considered [27]. Feranchak and colleagues showed during video and 
pH monitoring study that infants had excessive crying attacks during reflux 
episodes [28].
Regurgitation, vomiting, irritability, and refusal of feeding which are common 
in infants may be clinical signs of reflux although food allergies that may develop 
with the same clinical presentation especially in infant children should be included 
in the differential diagnosis. Remember that vomiting/regurgitation during infancy 
may be the first sign of systemic infection, sepsis, or many metabolic diseases other 
than reflux [29]. Alarm symptoms should be questioned, especially in infants with 
vomiting under 1 year of age (Table 2).
6. Diagnosis
The first step in making a definitive diagnosis in gastroesophageal reflux 
disease is to suspect. The findings should be questioned with careful and detailed 
history. Anamnesis and physical examination are the basis of the treatment. A 
specific diagnostic test is not required to diagnose reflux in the presence of recur-
rent postprandial vomiting with typical history, especially in infants under 1 year 
of age. However, if symptoms are not typical or if reflux-related complications 
are suspected, specific methods should be used. Many methods are used for the 
diagnosis of GER. Each of these methods is important in obtaining different 
information [10, 30–32].
6.1 Surveys
The diagnosis of GERD in adults can generally be made by anamnesis and 
clinical history [33]. Since the complaints are difficult to identify in children under 
Alarm symptoms in a vomiting baby
Presence of bile
Gastrointestinal bleeding
Presence of force vomiting
Failure to thrive
Presence of blood
Abdominal distension
Diarrhea
Fever
Lethargy
Hepatosplenomegaly
Bulging fontanel
Macro/microcephaly
Seizure
Suspected genetic/metabolic syndrome
Table 2. 
Alarm symptoms requiring further investigation in infants with regurgitation and vomiting.
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12 years of age, the history is less reliable [34, 35]. The questionnaire forms are 
aimed at increasing the reliability of the history rather than making the diagnosis. It 
is widely accepted surveys that I-GERQ-R developed by Orenstein et al. and GSQ-I 
and GSQ-YC prepared by Deal et al. could be used in infants with gastroesophageal 
reflux [10, 35–37].
6.2 Barium contrast radiography
An upper gastrointestinal (GI) series are not sensitive and specific for the 
diagnosis of GERD. Especially in studies comparing esophageal pH studies, sensitiv-
ity, specificity, and positive predictive values were found to be very low [38, 39]. 
Therefore, radiological evaluation is not an appropriate method to confirm or exclude 
GERD. However, it can be used especially in the evaluation of selected cases with 
atypical or severe symptoms such as dysphagia or odynophagia. In these patients pro-
vides recognition of anatomical disorders such as achalasia, tracheoesophageal fistula, 
esophageal stricture, hiatal hernia, antral web, pyloric stenosis, intestinal malrotation 
or peptic strictures [33, 39].
6.3 Nuclear scintigraphy
Nuclear scintigraphy is a method of demonstrating the spread of isotope in the 
esophagus, stomach, and lung by ingestion of technetium-labeled food or food. 
The potential advantage when compared with the esophageal pH study is that it 
also shows reflux of nonacidic gastric contents and determines gastric emptying 
rate [40, 41]. However, its sensitivity and specificity are lower than the pH study. 
Therefore, its place in the diagnosis of GERD is limited and is not routinely recom-
mended [24, 42].
6.4 Esophageal pH monitoring
The important advantages of 24 hr monitoring that can show the relationship 
between GERD and the patient’s symptoms and allow the baby to be monitored 
for a long time (night, day, according to the position of the body) in the physi-
ological environment [5]. It is used frequently in the diagnosis of patients with 
non-gastrointestinal symptoms (such as stridor, cough, hoarseness, chest pain) and 
in the evaluation of the response to medical treatment in patients with refractory 
gastroesophageal reflux [43, 44].
24 hr monitoring in esophagitis shows the duration, frequency of acidic reflux, 
and the degree of pH to which the esophagus is exposed [45]. Since it is a useful 
method in finding and evaluating reflux, it is widely accepted as the gold standard 
[43, 46, 47]. However, problems such as breast milk shifting the pH of the stomach 
to the alkaline side, the amount of reflux cannot be determined, and the pH probe 
cannot be fully inserted into the lower end of the esophagus are disadvantages of 
this method [45, 47].
6.5 Endoscopic evaluation
Esophageal endoscopy and biopsy are other valuable methods for the diagnosis 
of GERD. Endoscopy is used to diagnose complications such as erosive esophagitis, 
stricture, and Barrett’s esophagus. Esophageal biopsy can be used in the histological 
diagnosis of reflux esophagitis in the absence of erosion and in the differentiation of 
allergic and infection-induced esophagitis. It also helps to exclude diseases such as 
allergic or infectious esophagitis.
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The normal appearance of the esophagus on endoscopy does not exclude 
histopathological esophagitis. Minimal mucosal changes such as erythema and 
pallor may occur without esophagitis [48]. In one study, 87% of 62 patients with 
esophagitis had normal or mild mucosal changes endoscopically [49]. There are 
no eosinophils and neutrophils in the esophageal epithelium in healthy infants 
and children [50]. Intraepithelial eosinophilia, which is one of the diagnostic 
criteria for reflux esophagitis, shows that the esophagus is associated with long-
term reflux injury [51].
7. Treatment
Physiological reflux should be considered in the approach to gastroesophageal 
reflux for infants with congenital heart disease, and patients should be followed up 
closely (1–2 month periods). Treatment decisions should be made according to the 
current clinical situation and follow-up [10]. GERD treatment in infants consists of 
three main topics.
1. Conservative measures
2. Pharmacological treatment
3. Surgical treatment
7.1 Conservative measures
7.1.1 Lifestyle changes
Lifestyle changes or regulation may vary according to age in infants, young 
children, and older children/adolescents. However, what is known is that lifestyle 
changes are effective in the prevention of GERD in infants as well as in adults. 
Education of parents and awareness raising of reflux, nutritional and positional 
changes are involved in the management of physiological reflux [52–54]. Lifestyle 
changes in non-pathological reflux should be made before aggressive treatment 
approaches in infants with CHD such as healthy infants [10].
7.1.2 Positioning
Antireflux conservative measures recommended during infancy are not to feed the 
baby in a supine position, to allow time to release gas for decompression of the stomach 
in the middle of the feeding, to place the baby in an anti-Trendelenburg position at 30° 
after feeding, and not to allow constipation [54, 55]. Many studies have shown that 
infants lying in the prone position significantly reduce acid reflux compared to the flat 
supine position [56]. Although keeping the head higher in the prone position was found 
to reduce reflux further, no such difference was found in the supine position. Despite its 
positive effect on prevention of reflux, finding a relationship between prone position 
and sudden infant death prevented this method to be recommended. However, if the 
child is still observed, this position can be applied after feeding [57, 58].
7.1.3 Dietary change
Since breast-fed infants are less likely to have GERD than infants who take 
formula, the importance of breastfeeding should be explained and encouraged 
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them. In this age group, cow’s milk allergy symptoms (regurgitation, vomiting, 
sometimes refusal to feed, and restlessness) may not be distinguished from physi-
ological reflux [59–61]. Therefore, in infants with persistent reflux symptoms, cow 
milk elimination should be performed for 2–3 weeks, and the patient should be 
followed up. The significant reduction in vomiting and other symptoms during this 
period and recurrence of symptoms when the diet is impaired suggest cow’s milk 
allergy [62].
It has been shown that the thickening of formulas and nutrients prevents weight 
loss by reducing vomiting and regurgitation rather than reflux episodes. For this 
purpose, adding the products containing thickeners (rice cereal, corn or potato 
starch, and carob bean gum) to thickeners may reduce the frequency and volume of 
regurgitation [63].
7.2 Pharmacological treatment
Pharmacotherapy therapy is not indicated in infants with CHD who has uncom-
plicated gastroesophageal reflux because physiological reflux tends to improve over 
time. Pharmacotherapy should be considered in the treatment of gastroesophageal 
reflux disease in patients who do not respond despite thickened feedings, lifestyle 
changes, and nutritional recommendations [64, 65].
7.2.1 Proton pump inhibitors
This group prevents acid secretion by inhibiting Na+ - K+ ATPase, called proton 
pump, which is responsible for acid secretion in parietal cells. Proton pump inhibi-
tors, which have a stronger acid suppressant and mucosal curative effect than 
H2RAs, maintain gastric pH above 4 and inhibit food-borne acid secretion. It is 
also more effective in healing erosive esophagitis. It is also more effective in heal-
ing erosive esophagitis. Their efficacy is 24 hours, so they have the advantage of 
using a single dose per day. Proton pump inhibitors, omeprazole, lansoprazole, and 
esomeprazole, which can be used in the treatment of infants with gastroesophageal 
reflux, should be appropriately adjusted: omeprazole (infants: 3–<5 kg, 2.5 mg/
day; 5–<10 kg, 5 mg/day; ≥10 kg, 10 mg/day), esomeprazole (infants: 3–<5 kg, 
2.5 mg/day; 5–<10 kg, 5 mg/day; ≥10 kg, 10 mg/day), and lansoprazole (infants and 
children: 1 mg/kg/day [maximum 15 mg/day]) [38, 65].
There are potential risks of acid suppression due to PPI treatment in young chil-
dren, which can be evaluated in four categories: idiosyncratic reactions, drug-drug 
interactions, drug-induced hypergastrinemia, and drug-induced hypochlorhydria 
[66]. The most common idiosyncratic reactions were detected in 14% of children 
receiving PPI and showed effects such as headache, diarrhea, constipation, and 
nausea. They can be improved by reducing the dose or replacing it with a different 
preparation [67, 68].
7.2.2 H2 receptor antagonists
The mechanism of action of H2 receptor antagonists, which is mainly used in 
children under 1 year of age, is to reduce acid secretion by inhibiting histamine 2 
receptors in gastric parietal cells [53, 66]. Cimetidine, ranitidine, nizatidine, and 
famotidine are drugs in this group used in the treatment of reflux esophagitis. 
The frequency and dosage of use of these drugs in children are as follows: cimeti-
dine (children: 30–40 mg/kg/day divided into four doses); ranitidine (children: 
5–10 mg/kg/day divided into two to three doses), which is the most preferred drug 
in the treatment of infants and children; famotidine (children: 1 mg/kg/day divided 
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into two doses); and nizatidine (children: 10–20 mg/kg/day divided into two doses) 
[38]. Although H2 receptor antagonists reduce pepsin and gastric acid secretion, 
they do not reduce the frequency of gastroesophageal reflux and are less effective 
than proton pump inhibitors.
If they are used in reflux treatment for a long time (>14 days), tachyphylaxis 
and hypochlorhydria which can lead to bacterial colonization may occur. Common 
adverse events include increased risk of enteritis infection, especially C. difficile 
enteritis, drowsiness, dizziness, headache, abdominal pain, and diarrhea [69–71].
7.2.3 Antacids
The mechanism of action of antacids containing a combination of magnesium, 
aluminum hydroxide, or calcium carbonate is shown by neutralizing gastric acid. 
The use of aluminum-containing antacids in infants can cause osteopenia, micro-
cytic anemia, and neurotoxicity, so it is not suitable for use in infants [72].
7.2.4 Surface barrier agents
Alginate and sucralfate are used as surface protection agents in reflux treat-
ment [24, 73]. According to the results of the meta-analysis in 2017, alginates have 
been shown to be less effective than H2 receptor antagonists and proton pump 
inhibitors. Alginates are water-soluble salts of alginic acid and act as protective 
agents for the mucosal surface. Sodium and magnesium alginate preparations 
have been shown to significantly reduce vomiting symptoms even in preterm and 
term infants by pH/MMI studies [74]. Sucralfate, composed of sucrose sulfate 
aluminum, converts into a gel form with gastric acid and adheres to the mucosa, 
which is exposed to peptic erosion. Its efficacy has been shown in children in a 
limited number of studies, but there are not enough studies in terms of its efficacy 
and side effects and safety [75, 76].
7.2.5 Prokinetic agents
Metoclopramide, cisapride, domperidone, and baclofen are among the drugs 
in this group and can be used in the treatment of gastroesophageal reflux disease. 
However, cohort studies have shown that prokinetic drugs are not helpful in 
treatment of reflux [77]. In addition, these agents are not recommended for use in 
infants and children as they have important side effects such as lethargy, irritability, 
gynecomastia, galactorrhea, ventricular arrhythmias, QT prolongation, extrapyra-
midal reactions, and persistent tardive dyskinesia [78, 79].
7.3 Surgical treatment
Surgical procedures such as fundoplication (Nissen) are rarely performed under 
1 year of age for indications such as recurrent pneumonia and life-threatening 
reactive airway disease. It is a method that can be applied in the case of cardiopul-
monary insufficiency, which is unresponsive to medical treatment in patients  
with CHD [80, 81].
Conflicts of interest and sources of funding
The authors disclose that they received no financial support for this work. The 
authors declare no conflict of interest.
Differential Diagnosis of Chest Pain
10
Author details
Mehmet Semih Demirtaş*
1 Aksaray Unıversity Education And Research Hospital, Department of Pediatrics, 
Turkey
*Address all correspondence to: md.semihdemirtas@gmail.com
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
11
Approach to Gastroesophageal Reflux: A Cause of Chest Pain in Infants with Congenital Heart…
DOI: http://dx.doi.org/10.5772/intechopen.89327
References
[1] Bernstein D. Congenital heart 
disease. In: Behrman RE, Kliegman RM, 
Jenson HB, editors. Nelson Textbook 
of Pediatrics. 17th ed. United States of 
America: Saunders; 2004. pp. 1499-1554
[2] Özkutlu S, Günal N. Türkiye’de 
doğumsal kalp hastalıkları prevelansı, 
tanıdaki sosyoekonomik ve kültürel 
problemler yeni tanı metotlarının 
uygulanabilirliği çözümler. 
Türkiye Klinikleri Kardiyoloji. 
2003;4(16):369-371
[3] Costello CL, Gellatly M, Daniel J, 
Justo RN, Weir K. Growth restriction 
in infants and young children with 
congenital heart disease. Congenital 
Heart Disease. 2015;10(5):447-456
[4] Kuwata S, Iwamoto Y, Ishido H, 
Taketadu M, Tamura M, Senzaki H. 
Duodenal tube feeding: An alternative 
approach for effectively promoting 
weight gain in children with 
gastroesophageal reflux and congenital 
heart disease. Gastroenterology Research 
and Practice. 2013;2013:181604
[5] Leung AK. Gastroesophageal 
reflux. In: Leung AK, editor. Common 
Problems in Ambulatory Pediatrics: 
Specific Clinical Problems. Vol. 1. 
New York, NY: Nova Science Publishers, 
Inc.; 2011. pp. 7-13
[6] Winter HS. Management of 
Gastroesophageal Reflux Disease in 
Children and Adolescents. In: Post TW, 
ed. UpToDate. Waltham, MA [Accessed: 
1 April 2019].
[7] Forbes D, Lim A, Ravikumara M. 
Gastroesophageal reflux in the 21st 
century. Current Opinion in Pediatrics. 
2013;25(5):597-603. DOI: 10.1097/
MOP.0b013e328363ecf5
[8] Nelson SP, Chen EH, Syniar GM, 
et al. Prevalence of symptomatic 
gastroesophageal reflux during infancy. 
A pediatric practice-based survey, 
pediatric practice research group. 
Archives of Pediatrics & Adolescent 
Medicine. 1997;151:569-572
[9] De S, Rajeshwari K, Kalra KK, et al. 
Gastroesophageal reflux in infants 
and children in North India. Tropical 
Gastroenterology. 2001;22:99-102
[10] Demirtaş MS, Karakurt C, 
Selimoğlu A, Bağ HGG. Is 
gastroesophageal reflux disease a 
common complication in infants with 
congenital heart disease? Turkiye 
Klinikleri Journal of Pediatrics. 
2019;28(1):19-27. DOI: 10.5336/
pediatr.2018-63316
[11] El-Serag HB, Gilger M, Carter J, 
et al. Childhood GERD is a risk factor 
for GERD in adolescents and young 
adults. The American Journal of 
Gastroenterology. 2004;99:806-812
[12] Winter HS, Illueca M, Henderson C, 
Vaezi M. Review of the persistence 
of gastroesophageal reflux disease in 
children, adolescents and adults: Does 
gastroesophageal reflux disease in 
adults sometimes begin in childhood? 
Scandinavian Journal of Gastroenterol. 
Oct 2011;46(10):1157-1168. DOI: 
10.3109/00365521.2011.591425
[13] Orenstein SR, Shalaby TM, 
Finch R, et al. Autosomal dominant 
infantile gastroesophageal reflux 
disease: Exclusion of a 13q14 locus in 
five well-characterized families. The 
American Journal of Gastroenterology. 
2002;97(11):2725-2732
[14] Animasahun BA, Madise-Wobo AD, 
Kusimo OY. Cyanotic congenital heart 
diseases among Nigerian children. 
Cardiovascular Diagnosis and Therapy. 
2017;7:389-396
[15] Karacetin G, Demir T, Erkan T, 
Cokugras FC. Maternal psychopathology 
Differential Diagnosis of Chest Pain
12
and psychomotor development of 
children with gastroesophageal 
reflux disease. Journal of Pediatric 
Gastroenterology and Nutrition. Oct 
2011;53(4):380-385. DOI: 10.1097/
MPG.0b013e3182298caa
[16] Martin AJ, Pratt N, Kennedy JD, 
et al. Natural history and familial 
relationships of infant spilling to 9 years 
of age. Pediatrics. 2002;109:1061-1067
[17] Rubenstein JH, Chen JW. Epidemiology 
of gastroesophageal reflux disease. 
Gastroenterology Clinics of North 
America. 2014;43(1):1-14
[18] Carroll MW, Jacobson K. 
Gastroesophageal reflux disease 
in children and adolescents: When 
and how to treat. Paediatric Drugs. 
2012;14(2):79-89
[19] Arad-Cohen N, Cohen A, 
Tirosh E. The relationship between 
gastroesophageal reflux and apnea 
in infants. The Journal of Pediatrics. 
2000;137(3):321-326
[20] Orlanco RC. Pathophysiology 
of gastroesophageal reflux disease. 
In: Castell DO, Richter JE, editors. 
The Esophagus. 3rd ed. Philadelphia: 
Lippincott, Williams and Wilkins; 1999. 
pp. 409-419
[21] Medoff-Cooper B, Ravishankar C. 
Nutrition and growth in congenital 
heart disease: A challenge in children. 
Current Opinion in Cardiology. 
2013;28(2):122-129
[22] Cribbs RK, Heiss KF, Clabby ML, 
Wulkan ML. Gastric fundoplication is 
effective in promoting weight gain in 
children with severe congenital heart 
defects. Journal of Pediatric Surgery. 
2008;43(2):283-289
[23] Schumacher KR, Yu S, Butts R, 
et al. Fontan-associated protein-losing 
enteropathy and post–heart transplant 
outcomes: A multicenter study. 
The Journal of Heart and Lung 
Transplantation. 2019;38(1):17-25. DOI: 
10.1016/j.healun.2018.09.024
[24] Vandenplas Y, Rudolph CD, 
Di Lorenzo C, et al. Pediatric 
gastroesophageal reflux clinical practice 
guidelines: Joint recommendations 
of the North American Society for 
Pediatric Gastroenterology, Hepatology, 
and Nutrition (NASPGHAN) and 
the European Society for Pediatric 
Gastroenterology, Hepatology, 
and Nutrition. Journal of Pediatric 
Gastroenterology and Nutrition. 
2009;49(4):498-547
[25] Frankel EA, Shalaby TM, 
Orenstein SR. Sandifer syndrome 
posturing: Relation to abdominal wall 
contractions, gastroesophageal reflux, 
and fundoplication. Digestive Diseases 
and Sciences. 2006;51:635-640
[26] Kotagal P, Costa M, Wyllie E, 
Wolgamuth B. Paroxysmal nonepileptic 
events in children adolescents. 
Pediatrics. 2002;110:46
[27] Khan S, Orenstein SR. 
Gastroesophageal reflux disease 
in infants and children. In: 
Granderath FA, Kamolz T, Pointner R, 
editors. Gastroesophageal Reflux Disease. 
New York: Springer; 2006. pp. 45-64
[28] Feranchak AP, Orenstein SR, 
Cohn JF. Behaviors associated with 
onset of gastroesophageal reflux 
episodes in infants: Prospective study 
using split-screen video and pH probe. 
La Clinica Pediatrica. 1994;33:654-662
[29] Hegar B, Vandenplas Y. 
Gastroesophageal reflux: Natural 
evolution, diagnostic approach and 
treatment. The Turkish Journal of 
Pediatrics. 2013;55(1):1-7
[30] Rosen R. Gastroesophageal reflux in 
infants: More than just a phenomenon. 
JAMA Pediatrics. 2014;168(1):83-89. 
DOI: 10.1001/jamapediatrics.2013.2911
13
Approach to Gastroesophageal Reflux: A Cause of Chest Pain in Infants with Congenital Heart…
DOI: http://dx.doi.org/10.5772/intechopen.89327
[31] Sullivan JS, Sundaram SS. 
Gastroesophageal reflux. Pediatrics in 
Review. 2012;33(6):243-253; quiz 254. 
DOI: 10.1542/pir.33-6-243
[32] Sarath Kumar KS, Mungara J, 
Venumbaka NR, Vijayakumar P, 
Karunakaran D. Oral manifestations 
of gastroesophageal reflux disease in 
children: A preliminary observational 
study. Journal of the Indian Society of 
Pedodontics and Preventive Dentistry. 
2018;36(2):125-129. DOI: 10.4103/
JISPPD.JISPPD_1182_17
[33] Rosen R, Vandenplas Y, Singendonk M, 
et al. Pediatric Gastroesophageal Reflux 
Clinical Practice Guidelines: Joint 
Recommendations of the North American 
Society for Pediatric Gastroenterology, 
Hepatology, and Nutrition (NASPGHAN) 
and the European Society for Pediatric 
Gastroenterology, Hepatology, and 
Nutrition (ESPGHAN). Journal of 
Pediatric Gastroenterology and Nutrition. 
25 Jan 2018. DOI: 10.1097
[34] Salvia G, De Vizia B, Manguso F. 
Effect of intragastric volume and 
osmolality on mechanisms of 
gastroesophageal reflux in children with 
gastroesophageal reflux disease. The 
American Journal of Gastroenterology. 
2001;96:1725-1732
[35] Kleinman L, Revicki DA, Flood E. 
Validation issues in questionnaires 
for diagnosis and monitoring of 
gastroesophageal reflux disease in 
children. Current Gastroenterology 
Reports. 2006;8:230-236
[36] Orenstein SR, Cohn JF, Shalaby T. 
Reliability and validity of an infant 
gastroesophageal questionnaire. La 
Clinica Pediatrica. 1993;32:472-484
[37] Deal L, Gold BD, Gremse DA, 
Winter HS, et al. Age-specific 
questionnaires distinguish GERD 
symptom frequency and severity 
in bebeks and young children: 
Development and initial validation. 
Journal of Pediatric Gastroenterology 
and Nutrition. 2005;41:178-185
[38] Winter HS. Gastroesophageal 
Reflux in Infants. In: Post TW, ed. 
UpToDate. Waltham, MA[Accessed: 1 
April 2019].
[39] Chen MY, Ott DJ, Sinclair JW, 
et al. Gastroesophageal reflux disease: 
Correlation of esophageal pH testing 
and radiographic findings. Radiology. 
1992;185:483
[40] Seibert JJ, Byrne WJ, Euler AR, 
et al. Gastroesophageal reflux—The 
acid test: Scintigraphy or the pH 
probe? AJR. American Journal of 
Roentgenology. 1983;140:1087-1090
[41] Fawcett HD, Hayden CK, 
Adams JC, Swischuk LE. How useful is 
gastroesophageal reflux scintigraphy 
in suspected childhood aspiration? 
Pediatric Radiology. 1988;18:311-313
[42] Abell TL, Camilleri M, Donohoe K, 
et al. Consensus recommendations 
for gastric emptying scintigraphy: 
A joint report of the American 
Neurogastroenterology and Motility 
Society and the Society of Nuclear 
Medicine. The American Journal of 
Gastroenterology. 2008;103(3):753-763
[43] Jang HS, Lee JS, Lim GY, Choi BG, 
Choi GH, Park SH. Correlation of color 
Doppler sonographic findings with 
pH measurements in gastroesophageal 
reflux in children. Journal of Clinical 
Ultrasound. 2001;29(4):212-217.  
DOI: 10.1002/jcu.1022
[44] van der Pol RJ, Smits MJ, 
Venmans L, Boluyt N, Benninga MA, 
Tabbers MM. Diagnostic accuracy of 
tests in pediatric gastroesophageal 
reflux disease. The Journal of Pediatrics. 
2013;162(5):983.e1-987.e4. DOI: 
10.1016/j.jpeds.2012.10.041
[45] Lupu VV, Burlea M, Nistor N, 
et al. Correlation between esophageal 
Differential Diagnosis of Chest Pain
14
pH-metry and esophagitis in 
gastroesophageal reflux disease in 
children. Medicine (Baltimore). 
2018;97(37):e12042. DOI: 10.1097/
MD.0000000000012042
[46] Shay S. Esophageal impedance 
monitoring: The ups and downs 
of a new test. The American 
Journal of Gastroenterology. 
2004;99(6):1020-1022
[47] Vardar R, Keskin M. Indications 
of 24-h esophageal pH monitoring, 
capsule pH monitoring, combined 
pH monitoring with multichannel 
impedance, esophageal manometry, 
radiology and scintigraphy in 
gastroesophageal reflux disease? The 
Turkish Journal of Gastroenterology. 
2017;28(Suppl 1):S16-S21. DOI: 10.5152/
tjg.2017.06
[48] Martin R, Hibbs AM. 
Gastroesophageal Reflux in Premature 
Infants. In: Post TW, ed. UpToDate. 
Waltham, MA[Accessed: 1 April 2019].
[49] Black DD, Haggitt RC, 
Orenstein SR, et al. Esophagitis in 
infants. Morphometric histological 
diagnosis and correlation with 
measure of gastroesophageal reflux. 
Gastroenterology. 1990;98:1408-1414
[50] Tytgat G, Tytgat S. Esophageal 
biopsy. In: Scarpignato C, Galmiche 
J-P, editors. Functional Investigation in 
Esophageal Disease. Basel: Karger; 1994. 
pp. 13-26
[51] Lightdale JR, Gremse DA. 
Gastroesophageal reflux: Management 
guidance for the pediatrician. Pediatrics. 
2013;13(5):e1684-e1695
[52] Abu Jawdeh EG, Martin RJ. Neonatal 
apnea and gastroesophageal reflux 
(GER): Is there a problem? Early Human 
Development. 2013;89(Suppl 1): 
S14-S16. DOI: 10.1016/S0378- 
3782(13)70005-7
[53] Rostas SE, McPherson C. Acid 
suppression for gastroesophageal 
reflux disease in infants. Neonatal 
Network. 2018;37(1):33-41. DOI: 
10.1891/0730-0832.37.1.33
[54] Shalaby TM, Orenstein SR. Efficacy 
of telephone teaching of conservative 
therapy for infants with symptomatic 
gastroesophageal reflux referred 
by pediatricians to pediatric 
gastroenterologist. The Journal of 
Pediatrics. 2003;142:57-61
[55] Meyers WF, Herbst JJ. Effectiveness 
of positioning therapy for 
gastroesophageal reflux. Pediatrics. 
1982;62:768-772
[56] Tobin JM, McCloud P, 
Cameron DJ. Posture and gastro-
esophageal reflux: A case for left lateral 
positioning. Archives of Disease in 
Childhood. 1997;76:254-258
[57] Corvaglia L, Rotatori R, Ferlini M, 
et al. The effect of body positioning on 
gastroesophageal reflux in premature 
infants: Evaluation by combined 
impedance and pH monitoring. The 
Journal of Pediatrics. 2007;151:591-596
[58] Kaltenbach T, Crockett S, 
Gerson LB. Are lifestyle measures 
effective in patients with 
gastroesophageal reflux disease? An 
evidence-based approach. Archives of 
Internal Medicine. 2006;166:965-971
[59] Borrelli O, Mancini V, Thapar N, 
et al. Cow’s milk challenge increases 
weakly acidic reflux in children with 
cow’s milk allergy and gastroesophageal 
reflux disease. The Journal of Pediatrics. 
2012;161(3):476-481.e1. DOI: 10.1016/j.
jpeds.2012.03.002
[60] Nielsen RG, Bindslev-Jensen C, 
Kruse-Andersen S, Husby S. Severe 
gastroesophageal reflux disease and 
cow milk hypersensitivity in infants 
and children: disease association and 
15
Approach to Gastroesophageal Reflux: A Cause of Chest Pain in Infants with Congenital Heart…
DOI: http://dx.doi.org/10.5772/intechopen.89327
evaluation of a new challenge procedure. 
Journal of Pediatric Gastroenterology 
and Nutrition. 2004;39(4):383-391. 
PubMed PMID: 15448429
[61] Vandenplas Y, Gottrand F, 
Veereman-Wauters G, et al. 
Gastrointestinal manifestations 
of cow’s milk protein allergy and 
gastrointestinal motility. Acta 
Paediatrica. 2012;101(11):1105-1109. 
DOI: 10.1111/j.1651-2227.2012.02808.x
[62] Campanozzi A, Boccia G, 
Pensabene L, et al. Prevalence and 
natural history of gastroesophageal 
reflux: Pediatric prospective survey. 
Pediatrics. 2009;123(3):779-783. DOI: 
10.1542/peds.2007-3569
[63] Horvath A, Dziechciarz P, 
Szajewska H. The effect of thickened 
feed interventions on gastroesophageal 
reflux in infants: Systematic review and 
meta-analysis of randomized, controlled 
trials. Pediatrics. 2008;122:e1268-e1277
[64] Gibbons TE, Gold BD. The use of 
proton pump inhibitors in children: 
A comprehensive review. Paediatric 
Drugs. 2003;5:25-40
[65] Romano C, Chiaro A, Comito D, 
et al. Proton pump inhibitors in 
pediatrics: Evaluation of efficacy 
in GERD therapy. Current Clinical 
Pharmacology. 2011;6:41-47
[66] Mattos ÂZ, Marchese GM, 
Fonseca BB, Kupski C, Machado MB. 
Antisecretory treatment for 
pediatric gastroesophageal reflux 
disease—A systematic review. 
Arquivos de Gastroenterologia. 
2017;54(4):271-280. DOI: 10.1590/
s0004-2803.201700000-42
[67] Hassall E, Kerr W, El-Serag HB 
Characteristics of children receiving 
proton pump inhibitors continuously for 
up to 11 years duration. The Journal of 
Pediatrics. 2007;150:262-267
[68] Turco R, Martinelli M, Miele E, 
et al. Proton pump inhibitors as a risk 
factor for paediatric Clostridium difficile 
infection. Alimentary Pharmacology & 
Therapeutics. 2010;31(7):754-759. DOI: 
10.1111/j.1365-2036.2009.04229.x
[69] Adams DJ, Eberly MD, 
Rajnik M, Nylund CM. Risk factors 
for community-associated Clostridium 
difficile infection in children. The 
Journal of Pediatrics. 2017;186:105-109. 
DOI: 10.1016/j.jpeds.2017.03.032
[70] Canani RB, Cirillo P, Roggero P, 
et al. Therapy with gastric acidity 
inhibitors increases the risk of acute 
gastroenteritis and community-acquired 
pneumonia in children. Pediatrics. 
2006;117(5):e817-e820. DOI: 10.1542/
peds.2005-1655
[71] Freedberg DE, Lamousé-Smith ES, 
Lightdale JR, Jin Z, Yang YX, 
Abrams JA. Use of acid suppression 
medication is associated with risk 
for C. difficile infection in infants 
and children: A population-based 
study. Clinical Infectious Diseases. 
2015;61(6):912-917
[72] Leung AK, Lai PC. Use of 
metoclopramide for the treatment 
of gastroesophageal reflux in infants 
and children. Current Therapeutic 
Research, Clinical and Experimental. 
1984;36:911-915
[73] Simon B, Ravelli GP, Goffin H. 
Sucralfate gel versus placebo in patients 
with non-erosive gastro-oesophageal 
reflux disease. Alimentary 
Pharmacology & Therapeutics. 
1996;10:441-446
[74] Leiman DA, Riff BP, Morgan S, et al. 
Alginate therapy is effective treatment 
for gastroesophageal reflux disease 
symptoms: A systematic review 
and meta-analysis. Diseases of the 
Esophagus. 2017;30(2):1-8. DOI: 
10.1111/dote.12535
Differential Diagnosis of Chest Pain
16
[75] Atasay B, Erdeve O, Arsan S, 
Türmen T. Effect of sodium alginate 
on acid gastroesophageal reflux disease 
in preterm infants: A pilot study. The 
Journal of Clinical Pharmacology. 
2010;50:1267-1272. [Epub: 20 May 
2010]
[76] Corvaglia L, Aceti A, Mariani E, 
et al. The efficacy of sodium alginate 
(Gaviscon) for the treatment of 
gastro-oesophageal reflux in preterm 
infants. Alimentary Pharmacology & 
Therapeutics. 2011;33:466-470. [Epub: 
15 December 2010]
[77] Tolia V, Calhoun J, Kuhns L, 
Kauffman RE. Randomized, prospective 
double-blind trial of metoclopramide 
and placebo for gastroesophageal reflux 
in infants. The Journal of Pediatrics. 
1989;115(1):141-145. PubMed PMID: 
2661788
[78] Dalby-Payne JR, Morris AM, 
Craig JC. Meta-analysis of randomized 
controlled trials on the benefits 
and risks of using cisapride for the 
treatment of gastroesophageal reflux in 
children. Journal of Gastroenterology 
and Hepatology. 2003;18:196-202
[79] Hibbs AM, Lorch SA. 
Metoclopramide for the treatment 
of gastroesophageal reflux disease in 
infants: A systematic review. Pediatrics. 
2006;118:746-752
[80] Wakeman DS, Wilson NA, 
Warner BW. Current status of surgical 
management of gastroesophageal 
reflux in children. Current Opinion in 
Pediatrics. 2016;28(3):356-362. DOI: 
10.1097/MOP.000000000000341
[81] Kane TD, Brown MF, Chen MK, 
et al. Position paper on laparoscopic 
antireflux operations in infants and 
children for gastroesophageal reflux 
disease. American Pediatric Surgery 
Association. Journal of Pediatric 
Surgery. 2009;44:1034-1040
